Stephanie A Smith Selected Research

Stephanie A Smith Research Topics

Disease

16	Polyps 01/2022 - 10/2007
16	Thrombosis (Thrombus) 07/2021 - 12/2009
9	Inflammation (Inflammations) 11/2020 - 06/2012
7	Hemorrhage 01/2022 - 12/2011
4	Hyperglycemia 04/2013 - 01/2003
3	Venous Thrombosis (Deep-Vein Thrombosis) 11/2020 - 09/2003
2	Thromboinflammation 07/2021 - 01/2021
2	Sepsis (Septicemia) 12/2020 - 01/2018
2	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 11/2020 - 09/2020
2	COVID-19 11/2020 - 09/2020
2	Thrombophilia 11/2020 - 09/2020
2	Thromboembolism 11/2016 - 01/2003
2	Pulmonary Embolism 11/2010 - 12/2009
1	Infections 12/2020
1	Wounds and Injuries (Trauma) 11/2020
1	Transfusion-Related Acute Lung Injury 09/2020
1	Thrombocytopenia (Thrombopenia) 11/2016
1	Insulin Resistance 04/2013
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 04/2013

Drug/Important Bio-Agent (IBA)

26	PolyphosphatesIBA 01/2022 - 10/2007
11	PolymersIBA 01/2020 - 10/2007
7	Phosphates (Orthophosphate)IBA 01/2020 - 12/2009
6	Thrombin FDA Link 12/2021 - 09/2003
5	FibrinIBA 11/2020 - 01/2015
4	Histones (Histone)IBA 07/2021 - 06/2017
4	DNA (Deoxyribonucleic Acid)IBA 09/2020 - 06/2017
4	Complement System Proteins (Complement)IBA 01/2019 - 09/2014
4	Peptide Hydrolases (Proteases)FDA Link 01/2016 - 12/2009
3	Heparin (Liquaemin)FDA LinkGeneric 01/2022 - 01/2016
3	EnzymesIBA 01/2020 - 01/2003
3	CalciumIBA 12/2018 - 01/2002
3	Nucleic AcidsIBA 10/2018 - 10/2007
3	Factor XIIa (Coagulation Factor XIIa)IBA 01/2017 - 11/2010
3	Factor XII (Hageman Factor)IBA 01/2016 - 12/2009
3	Factor XI (Plasma Thromboplastin Antecedent)IBA 12/2011 - 12/2009
2	defibrotideIBA 07/2021 - 01/2021
2	AutoantibodiesIBA 11/2020 - 09/2020
2	Immunoglobulin G (IgG)IBA 11/2020 - 09/2020
2	AntibodiesIBA 11/2020 - 11/2016
2	Phospholipids (Phosphatides)FDA LinkGeneric 11/2020 - 09/2020
2	Carrier Proteins (Binding Protein)IBA 11/2020 - 09/2020
2	Prothrombin (Factor II)IBA 09/2020 - 01/2017
2	polyacrylamideIBA 01/2020 - 10/2018
2	BradykininIBA 01/2019 - 12/2009
2	Proteins (Proteins, Gene)FDA Link 12/2018 - 01/2016
2	GelsIBA 10/2018 - 10/2007
2	Blood Coagulation Factors (Coagulation Factor)IBA 01/2018 - 01/2016
2	CollagenIBA 01/2018 - 11/2010
2	RNA (Ribonucleic Acid)IBA 01/2018 - 01/2017
2	Fibrinogen (Factor I)FDA Link 01/2018 - 10/2012
2	Plasma KallikreinIBA 01/2017 - 12/2009
2	Thromboplastin (Tissue Factor)IBA 01/2017 - 11/2010
2	Glucose (Dextrose)FDA LinkGeneric 04/2013 - 10/2012
2	GlucocorticoidsIBA 04/2006 - 01/2002
1	Dendrimers (Dendrons)IBA 01/2022
1	polyglycerolIBA 01/2022
1	PolyethyleneimineIBA 01/2022
1	UHRA-10IBA 01/2022
1	polycationsIBA 01/2022
1	exopolyphosphataseIBA 12/2020
1	Immunoglobulin A (IgA)IBA 09/2020
1	PhosphatidylserinesIBA 09/2020
1	Antiphospholipid AntibodiesIBA 09/2020
1	Immunoglobulin M (IgM)IBA 09/2020
1	Glycoproteins (Glycoprotein)IBA 09/2020
1	PowdersIBA 01/2020
1	Ethanol (Ethyl Alcohol)IBA 01/2020
1	Food Additives (Food Additive)IBA 01/2020
1	Escherichia coli Ppx proteinIBA 12/2018
1	Coloring Agents (Dyes)IBA 10/2018
1	P-SelectinIBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	SolutionsIBA 10/2017
1	Dihydrotachysterol (AT 10)IBA 10/2017
1	ChromatinIBA 06/2017
1	High-Molecular-Weight Kininogen (Kininogen, High Molecular Weight)IBA 01/2017
1	Ellagic AcidIBA 01/2017
1	Factor XIa (Coagulation Factor XIa)IBA 01/2017
1	Platelet Factor 4IBA 11/2016
1	Antigen-Antibody Complex (Immune Complex)IBA 11/2016
1	GoldIBA 01/2016
1	CystamineIBA 01/2016
1	Liposomes (Liposome)IBA 01/2016
1	LectinsIBA 01/2016
1	Serine Proteases (Serine Protease)IBA 01/2016
1	AnticoagulantsIBA 06/2015
1	Polymethyl Methacrylate (Sol)IBA 06/2015
1	Silicon Dioxide (Silica)FDA LinkGeneric 03/2015
1	SuspensionsIBA 11/2014
1	BuffersIBA 11/2014
1	MagnesiumIBA 11/2014
1	AlbuminsIBA 11/2014
1	Nonesterified Fatty Acids (NEFA)IBA 04/2013
1	CarbohydratesIBA 04/2013
1	Dietary Fats (Dietary Fat)IBA 04/2013
1	Insulin (Novolin)FDA Link 04/2013
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 12/2012

Therapy/Procedure

2	Therapeutics 06/2015 - 01/2002
1	Glycemic Control 04/2013
1	Catheters 10/2012